DocuSign Inc. (DOCU)

DocuSign's stock sits near the top of its 52-week range, but the rally has slowed into the 20-day average, and Wall Street remains cautious. The price of $77.66 is 6.23% above its 50-day average and 40.31% above its 200-day average, which keeps the trend up. Analysts are split and lean toward holding: 4 of 20 rate the stock buy or strong buy, 15 rate it hold, and 1 rates it sell, with a median 12-month target of $72.00 that sits below the current price. The stock is trading at a premium to sector peers on earnings, while revenue growth lags the sector. The next few sessions will test whether the shares can clear the 20-day average and whether growth re-accelerates.

DocuSign has beaten the EPS estimate in each of the last eight reports, the most recent on September 3, 2026, when adjusted EPS of $1.16 came in 6.42% above the estimate and the shares rose 3.70% in the first session. The record is consistent, yet the market has not rewarded every beat. The June 4, 2026 report beat by 10.10%, but the shares fell 7.22% in the first session, and the December 4, 2025 report beat by 9.78% before a 7.64% drop. Across the eight reports, three beats were followed by a lower share price, which shows investors are looking past headline EPS to growth and guidance.

Revenue grew 9.40% in the latest quarter compared with the same quarter a year earlier, which trails the sector median of 24.2% by 14.8 percentage points. At a trailing P/E of 47.41, the stock trades at a premium to peers, with the sector median P/E at 35.1. Its price-to-sales ratio of 4.32 is well below the sector median of 7.6, so the premium rests on earnings rather than on sales. Profitability supports the case: the net profit margin is 9.82%, the operating margin is 13.43%, return on equity is 17.80% against a sector median of 13.4%, and debt-to-equity is 0.11.

On September 4, 2026, Piper Sandler, Citigroup, Morgan Stanley, B of A Securities, Baird and Wells Fargo all kept their ratings unchanged, with B of A Securities staying at Underperform. Of 20 analysts with a current rating, 4 rate the stock buy or strong buy, 15 hold it and 1 sells it, which is a Hold consensus. Three months earlier, 5 of 22 ratings were buy, so the number of buy ratings has fallen. The median 12-month target of $72.00 is 7.3% below the price, and the range from $46.89 to $86.00 is wide.

Insiders sold $34.7M of stock across recent filings over the last 18 months, and no open-market purchases were recorded in that period. Insider sales are often planned in advance or made to cover taxes on vesting shares, so they are a weaker signal than purchases by insiders with their own money, but the absence of buying is still notable for a stock trading at a premium.

The base case is that DOCU trades in a range between its 50-day average and its 52-week high while the business continues to beat earnings estimates. Eight of the last eight reports beat the EPS estimate, which supports the stock, but three of those beats were followed by a lower share price the next session, so beats alone have not guaranteed gains. For the stock to extend the rally, it needs to hold above the 50-day average at $73.11 and push through the 20-day EMA at $78.55 toward the 52-week high of $85.90. Revenue growth of 9.40% against a sector median of 24.2% is the main drag; a visible pickup in growth would strengthen the case for the premium valuation. A fall back toward the 50-day average would bring the median analyst target of $72.00 into view, and a break of the 50-day average would weaken the trend that currently supports the shares. The analysts' range runs from $46.89 to $86.00, so the outcome depends heavily on how the growth gap closes.

Support sits at the 50-day simple moving average of $73.11, the nearest level below the price; a move down would first test this average, which has been rising and is well above the 200-day average. The second support is the 200-day simple moving average of $55.35, which marks the longer-term trend line. The third is the 52-week low of $40.16. Resistance begins at the 20-day exponential moving average of $78.55, the nearest level above the price, where the short-term trend is being tested. Above that, the 52-week high of $85.90 is the next resistance and the level the stock would need to clear to set new highs.